Meacci E - Search Results

1

Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.

Laffi G, Marra F, Buzzelli G, Azzena G, Meacci E, De Feo ML, La Villa G, Gentilini P. Laffi G, et al. Among authors: meacci e. Hepatology. 1991 Jun;13(6):1101-5. Hepatology. 1991. PMID: 2050329 Clinical Trial.

2

Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure.

La Villa G, Marra F, Laffi G, Belli B, Meacci E, Fascetti P, Gentilini P. La Villa G, et al. Among authors: meacci e. Eur J Clin Pharmacol. 1989;37(1):1-5. doi: 10.1007/BF00609415. Eur J Clin Pharmacol. 1989. PMID: 2512175 Clinical Trial.

3

Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites.

Laffi G, Marra F, Pinzani M, Meacci E, Tosti-Guerra C, De Feo ML, Gentilini P. Laffi G, et al. Among authors: meacci e. Liver. 1989 Dec;9(6):315-21. doi: 10.1111/j.1600-0676.1989.tb00418.x. Liver. 1989. PMID: 2532698

4

Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.

Laffi G, Pinzani M, Meacci E, La Villa G, Renzi D, Baldi E, Cominelli F, Marra F, Gentilini P. Laffi G, et al. Among authors: meacci e. Gastroenterology. 1989 Jan;96(1):167-77. doi: 10.1016/0016-5085(89)90777-4. Gastroenterology. 1989. PMID: 2535828

5

Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.

Meacci E, Smorlesi C, Chiarantini E, Birardi A, Buzzelli G. Meacci E, et al. Boll Soc Ital Biol Sper. 1987 Jun 30;63(6):489-95. Boll Soc Ital Biol Sper. 1987. PMID: 2820446 No abstract available.

6

Galactose loading tests in patients with hepatocellular carcinoma for the assessment of chemotherapy.

Buzzelli G, Meacci E, Smorlesi C, Chiarantini E, Birardi A, Gentilini P. Buzzelli G, et al. Among authors: meacci e. Chemioterapia. 1987 Aug;6(4):306-9. Chemioterapia. 1987. PMID: 2820595

7

Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis.

Laffi G, Cominelli F, La Villa G, Fedi S, Pinzani M, Meacci E, Gentilini P. Laffi G, et al. Among authors: meacci e. Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:366-9. Adv Prostaglandin Thromboxane Leukot Res. 1987. PMID: 2959079 No abstract available.

8

Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites.

Pinzani M, Laffi G, Meacci E, La Villa G, Cominelli F, Gentilini P. Pinzani M, et al. Among authors: meacci e. Gastroenterology. 1988 Oct;95(4):1081-7. doi: 10.1016/0016-5085(88)90186-2. Gastroenterology. 1988. PMID: 3165896

9

Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.

Gentilini P, Laffi G, Meacci E, La Villa G, Cominelli F, Pinzani M, Buzzelli G. Gentilini P, et al. Among authors: meacci e. Gastroenterology. 1988 Jun;94(6):1470-7. doi: 10.1016/0016-5085(88)90688-9. Gastroenterology. 1988. PMID: 3360268

10

Systemic haemodynamics, renal and platelet function during chronic propranolol administration in patients with compensated cirrhosis.

Meacci E, La Villa G, Laffi G, Cominelli F, Di Donato M, Dabizzi P, Albani F, Gentilini P. Meacci E, et al. Liver. 1987 Apr;7(2):110-5. doi: 10.1111/j.1600-0676.1987.tb00326.x. Liver. 1987. PMID: 3475523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters